Navigation Links
OmniComm Systems, Inc. Announces 2010 First Half Results
Date:7/27/2010

FORT LAUDERDALE, Fla., July 27 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC: OMCM), a global provider of eClinical solutions and services announced its results of operations for the first half of fiscal 2010.  

New contracts for OmniComm products and services surpassed $6.9M during the first half of 2010, a 51% increase over first half of 2009.  Software as a Service (SaaS) contracts showed a steady increase over last year at this time, and technology transfer/licensing contracts showed a significant increase, comprising 70% of the new business in 2010.  Revenue for the first half totaled $5.9 million compared to revenues in the first half of last year of $4.2 million- a 40% increase year-over-year.

"During the first half of 2010, approximately 44% of our revenue has come from licensing and 12% has come from our European operations," remarked Stephen Johnson, President and Chief Operating Officer. "Coming into the year, two of our primary goals were to substantially grow our licensing revenue and to leverage our existing European operations in Germany and England to garner more international market share.  It's rewarding to see our efforts paying off."

Milestones for First Half 2010:

  • New contracts signed in the first half, totaled $6,945,450, up approximately 51% compared to the same period in 2009 at $4,601,974.
  • Revenues for the period were approximately $5.9 million, an increase of approximately  44% over 2009 revenues for the same period
  • Our diversified customer base includes the following industries:
    • Academic and Research  -21%
    • Biotech – 23%
    • CRO – 19%
    • Pharma – 18%
    • Medical Device – 19%
  • Revenue from our European clients have grown to approximately 12% of our total revenues as a result of the two acquisitions completed during 2009
  • We bolstered our senior management team by promoting Stephen Johnson to President & Chief Operating Officer, Ken Light to Executive Vice President of Operations, and added Bev Hudson as Senior Vice President of Business Development

"We are pleased with the growth and diversification we have achieved during the first six months of 2010," commented Ronald Linares, Executive Vice President and Chief Financial Officer. "We believe that we have positioned ourselves to capitalize on growth throughout the clinical trials arena through our diversification efforts.  We have added several new software applications and related services and substantially increased our operating footprint within Europe.  We have seen some signs of increased spending in the clinical trial R & D arena and are optimistic that as the overall economy continues its recovery that we will be poised for continued growth."

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's pricing model is easily understood and allows companies ranging from small, to large, to maximize their clinical research investments. OmniComm Systems, Inc has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.

Safe Harbor Disclaimer

Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT:

Mark Rice

OmniComm Systems, Inc.

858-259-2365

mjrice@omnicomm.com


'/>"/>
SOURCE OmniComm Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
2. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
3. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
4. United American Healthcare Corporation Announces Acquisition of Pulse Systems, LLC
5. Simulated Surgical Systems, LLC Partners to Bring Simulation Advances to Surgical Training
6. ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors
7. McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010
8. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
9. Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc.
10. Millar Instruments and Transonic Systems, Suppliers of Gold Standard Pressure and Flow Products, Enter Into Mutual Distribution Agreement
11. Delcath Systems, Inc. Prices $30.6 Million Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):